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PLANT INTERFERON MAY HAVE MEDICAL USES




Interferon, the anti-virus protein substance that is being tested as an 
anti-cancer drug, may be present in plants, according to University of Montana 
botany professor and researcher Meyer Chessin.
The significance of plant interferon, Chessin said, is its close similarities 
to human and animal interferon and its possible medical applications.
So far animal and human interferons are difficult and expensive to obtain 
for research and use in human disease therapy even with genetic engineering and 
other modifications. Chessin cautiously predicts that plants may be an easier 
and less costly interferon source for potential animal and human therapy.
However, most attention and funding have gone to mammalian interferon 
research, Chessin points out. He hopes that a new trend will develop to supply 
more funds for research into plant interferon physiology, virus infection 
resistance, and direct applications.
Chessin summarized the history of plant interferon research and some of his 
own recent work with the substance in an article published in the March issue of 
The Botanical Review. The article made a strong case for the existence and
I
potential uses of plant interferon and sparked international interest in Chessin's 
theories--he has answered hundreds of requests from more than 65 countries for
(over)
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reprints of the article.
The research has been international in scope as well. Chessin's first 
serious steps toward investigating plant interferon began with discussions he 
had with colleagues in Romania almost 13 years ago.
In 1975, Chessin and Gad Loebenstein, head of the Volcani Institute 
Agricultural Research Center in Bet Dagan, Israel, began collaborating on 
pi ant-interferon research. They recently received a renewed three-year grant 
from the U.S.-Israel Bi-national Agricultural Research Development (BARD) Fund 
to continue their studies.
For his part of the grant, Chessin has been researching the physiology 
and chemical makeup of plant interferon to determine whether it is an interferon 
as known in animal physiology. Loebenstein has been testing its applicability 
as an interferon and its anti-disease effects in plants.
Chessin reported that Loebenstein has used a plant-interferon spray 
preparation that was effective against viral infections in plants. He also cited 
some earlier research that indicated RNA from a rice dwarf-virus had some success 
in inducing interferon in animal cells.
And although an animal interferon preparation was effective against tobacco- 
mosaic virus, Chessin said it is not yet known that a piant-to-animal interferon 
will also succeed.
He carefully emphasized that such experiments have been few, very isolated 
and therefore are inconclusive. However, he feels that they are promising and 
worthy of further study.
Chessin is optimistic about the existence and uses of plant interferon.
He reports that the chemical compound meets two of the three criteria to qualify 
as an interferon: it is both an anti-viral protein, which is induced by viral
infection, and it is not limited to specific viruses--that is, it acts against 
several kinds of plant viruses.
(more)
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The third criterion is yet unanswered: does the compound cause anti-viral 
activity that results from its induction of RNA and proteins in cells? The 
solution to this question is one of the main areas Chessin is investigating at UM 
with the help of doctoral student Amitava Mitra, who is from Calcutta, India.
Their research studies whether the plant compound has the two-phase action 
of interferon: first, that interferon is induced by the activity of viruses 
and, second, that the interferon causes the anti-virus action.
If the compound fulfills these phases, then it could be definitely labeled 
as an interferon. Chessin said subsequent research would then try to determine 
whether and how it could be used or be adapted to use in medical therapy in 
animals and humans.
The work of the next three years, Chessin speculated, should give the researchers 
a much better idea about the characteristics of plant interferon and its possible 
uses.
Chessin said he has applied for a grant from the National Science Foundation 
which would support his work and that of his Romanian colleagues. The purpose 
of the grant would be to explore further the possible cross-overs of plant interferon 
into animal-kingdom and human virus resistance.
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